Translation inhibitors in chronically activated PDGFRA cells (WP4566)
Homo sapiens
Chronic stimulation of the PDGFRA receptor results in decreased phosphorylation of RSK1/2 and S6K1/2, which subsequently impairs the phosphorylation of S6 ribosome protein and associated ribosome biogenesis and 5′ TOP mRNA translation. The phosphorylation of 4EBP1 and PDCD4 are suppressed, which subsequently limits the components of the eIF4F complex (eIF4E and eIF4A) from joining into the complex. In addition, the phosphorylation of the translation initiation factor eIF4B is also decreased. These changes result in a suppressed CAP-dependent translation initiation in cells with chronic stimulated PDGFRA signaling compared with acute stimulated ones. Based on figure S7 from [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238596/ Zhou et al]. Protein phosphorylation sites were added based on information from PhosphoSitePlus (R), www.phosphosite.org.
Authors
Kristina Hanspers , Andra Waagmeester , Denise Slenter , Alex Pico , and Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
CPTAC ExRNAAnnotations
Pathway Ontology
glioma pathway translation initiation pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
AZD8055 | Metabolite | chebi:91329 | |
4EGI-1 | Metabolite | pubchem.compound:6911989 | |
PRKCD | GeneProduct | ensembl:ENSG00000163932 | |
MAPK14 | GeneProduct | ensembl:ENSG00000112062 | |
MAP2K4 | GeneProduct | ensembl:ENSG00000065559 | |
RPS6KA1 | GeneProduct | ensembl:ENSG00000117676 | |
RPS6 | GeneProduct | ensembl:ENSG00000137154 | |
RPS6KA4 | GeneProduct | ensembl:ENSG00000162302 | |
RPS6KB1 | GeneProduct | ensembl:ENSG00000108443 | |
PIM1 | GeneProduct | ensembl:ENSG00000137193 | |
PDK1 | GeneProduct | ensembl:ENSG00000152256 | |
RPS6KB2 | GeneProduct | ensembl:ENSG00000175634 | |
AKT1 | GeneProduct | ensembl:ENSG00000142208 | |
PDCD4 | GeneProduct | ensembl:ENSG00000150593 | |
MTOR | GeneProduct | ensembl:ENSG00000198793 | |
RPTOR | GeneProduct | ensembl:ENSG00000141564 | |
MAP2K1 | GeneProduct | ncbigene:5604 | |
MAPK1 | GeneProduct | ncbigene:5594 | |
MAPK3 | GeneProduct | ncbigene:5595 | |
MAP2K2 | GeneProduct | ncbigene:5605 | |
PIK3CA | GeneProduct | ensembl:ENSG00000121879 | |
PIK3CB | GeneProduct | ensembl:ENSG00000051382 | |
PIK3R1 | GeneProduct | ensembl:ENSG00000145675 | |
PIK3R2 | GeneProduct | ensembl:ENSG00000105647 | |
PIK3R3 | GeneProduct | ensembl:ENSG00000117461 | |
PIK3CG | GeneProduct | ensembl:ENSG00000105851 | |
MAP2K5 | GeneProduct | ensembl:ENSG00000137764 | |
MAP2K6 | GeneProduct | ensembl:ENSG00000108984 | |
MAP2K7 | GeneProduct | ensembl:ENSG00000076984 | |
MAPK9 | GeneProduct | ncbigene:5601 | |
MAPK10 | GeneProduct | ncbigene:5602 | |
MAPK8 | GeneProduct | ncbigene:5599 | |
MAP2K3 | GeneProduct | ensembl:ENSG00000034152 | |
PRKCA | GeneProduct | ensembl:ENSG00000154229 | |
RPS6KA5 | GeneProduct | ensembl:ENSG00000100784 | |
CSNK2A1 | GeneProduct | ensembl:ENSG00000101266 | |
PRKACA | GeneProduct | ensembl:ENSG00000072062 | |
RPS6KA2 | GeneProduct | ensembl:ENSG00000071242 | |
AKT2 | GeneProduct | ensembl:ENSG00000105221 | |
AKT3 | GeneProduct | ensembl:ENSG00000117020 | |
EIF4EBP1 | GeneProduct | ncbigene:1978 | |
EIF4E | GeneProduct | ncbigene:1977 | |
EIF4A1 | GeneProduct | ncbigene:1973 | |
EIF4A2 | GeneProduct | ncbigene:1974 | |
EIF4G3 | GeneProduct | ncbigene:8672 | |
EIF4G1 | GeneProduct | ncbigene:1981 | TrEMBL accession number O43177 refers to same protein. |
PIM2 | GeneProduct | ensembl:ENSG00000102096 | |
EIF4B | GeneProduct | ncbigene:1975 |
References
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20. PubMed Europe PMC Scholia
- Chronic platelet-derived growth factor receptor signaling exerts control over initiation of protein translation in glioma. Zhou S, Appleman VA, Rose CM, Jun HJ, Yang J, Zhou Y, et al. Life Sci Alliance. 2018 Jun 19;1(3):e201800029. PubMed Europe PMC Scholia